FDA Green Lights Marijuana-Based Pharmaceutical Drug
For the first time, the FDA has approved a drug containing CBD, an extract of marijuana. This move could pave the way for more research into medical uses for the marijuana extract.
The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
The drug is made from purified cannabidiol, or CBD, a compound found in the cannabis
